Eribulin inhibits growth of cutaneous squamous cell carcinoma cell lines and a novel patient-derived xenograft
Article in Scientific Reports (May 2023)
The most recent citing publications are shown below. View all 29 publications that cite this research output on Dimensions.
Article in Scientific Reports (May 2023)
Article in Frontiers in Bioscience-Landmark (March 2023)
Preprint in Research Square (February 2023)